W6 - Introduction to the Pharmaceutical Benefits Scheme (PBS)

When was the initial pharmaceutical scheme in Australia established?

1919, for war veterans.

What significant event regarding the PBS occurred in 1948?

The Pharmaceutical Benefits Scheme (PBS) began, initially providing medicines for pensioners and disease prevention.

What committee was established in 1953 to evaluate drugs for the PBS?

The Pharmaceutical Benefits Advisory Committee (PBAC).

What is the role of the Therapeutic Goods Administration (TGA) in relation to the PBS?

The TGA determines if medicines and other therapeutic substances can be marketed in Australia.

What three criteria does the TGA assess for medicines?

Quality, Safety, and Efficacy.

What is the function of the Pharmaceutical Benefits Advisory Committee (PBAC)?

To provide recommendations to the government on which medicines should be available under subsidy from the PBS.

What determines the size of patient co-payments under the PBS?

The income status of the person.

What is a major concern regarding PBS expenditure?

The introduction of new, heavily promoted, and highly expensive drugs.

What is the National Medicines Policy 2022?

A framework focusing on the availability of medicines, their use, and medicine services.

What are the four pillars of the National Medicines Policy 2022?

1. Equitable access to medicines; 2. Quality use of medicines; 3. Sustainable medicines industry; 4. Accountability and transparency.

What does the PBS aim to achieve in terms of patient access to medicines?

Timely, safe, and reliable access to medicines and medicines-related services at affordable costs.

What historical event in 1944 influenced the PBS's development?

The proposal of the first non-veteran pharmaceutical scheme, which faced challenges due to nationalised medicine.

What is the process for a medicine to be listed on the PBS?

It must be approved for sale by the TGA and evaluated by the PBAC.

What is a key challenge faced by the PBS today?

Managing the costs associated with new and expensive medications.